🔎 Trials Near Me

Home › Laryngeal Cancer › North Dakota

Laryngeal Cancer clinical trials in North Dakota

5 studies for Laryngeal Cancer are looking for participants at sites in North Dakota.

Cities in North Dakota

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

  • Sanford Bismarck Medical Center, Bismarck
  • Sanford Broadway Medical Center, Fargo
  • Sanford Roger Maris Cancer Center, Fargo
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06589804

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Sanford Bismarck Medical Center, Bismarck
  • Essentia Health Cancer Center-South University Clinic, Fargo
  • Sanford Broadway Medical Center, Fargo
  • and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05136196

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

  • Sanford Bismarck Medical Center, Bismarck
  • Essentia Health Cancer Center-South University Clinic, Fargo
  • Sanford South University Medical Center, Fargo
  • and 3 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT02734537

Integrated Cancer Repository for Cancer Research

  • Essentia Health, Fargo
  • Trinity Hospital Cancer Care Center, Minot
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Fargo
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.